TuisONCY • NASDAQ
add
Oncolytics Biotech Inc
Vorige sluiting
$0,94
Dagwisseling
$0,94 - $0,96
Jaarwisseling
$0,33 - $1,51
Markkapitalisasie
93,40 m USD
Gemiddelde volume
856,69 k
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (CAD) | Sep. 2025info | J/J-verandering |
|---|---|---|
Inkomste | — | — |
Bedryfskoste | 13,84 m | 39,81% |
Netto inkomste | -14,40 m | -50,90% |
Netto winsgrens | — | — |
Wins per aandeel | -0,14 | -16,67% |
EBITDA | -13,82 m | -40,08% |
Effektiewe belastingkoers | 1,72% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (CAD) | Sep. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 12,35 m | -36,97% |
Totale bates | 15,06 m | -37,94% |
Totale aanspreeklikheid | 14,94 m | -1,73% |
Totale ekwiteit | 115,00 k | — |
Uitstaande aandele | 106,15 m | — |
Prys om te bespreek | ∞ | — |
Opbrengs op bates | -197,54% | — |
Opbrengs op kapitaal | -872,97% | — |
Kontantvloei
Netto kontantverandering
| (CAD) | Sep. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | -14,40 m | -50,90% |
Kontant van bedrywe | -6,65 m | -37,64% |
Kontant van beleggings | -7,00 k | 78,12% |
Kontant van finansiering | 4,14 m | 2 491,91% |
Netto kontantverandering | -2,27 m | 56,70% |
Beskikbare kontantvloei | -765,00 k | 55,05% |
Meer oor
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that: induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
Gestig
1998
Hoofkwartier
Webwerf
Werknemers
28
